## **Core Concept**
Ticlopidine is a medication used to prevent blood clots. It belongs to a class of drugs known as antiplatelet agents, which work by inhibiting platelet aggregation. This is crucial in preventing thrombotic events such as strokes and myocardial infarctions.

## **Why the Correct Answer is Right**
Ticlopidine is specifically classified as a **thienopyridine**, a subclass of antiplatelet drugs. Thienopyridines work by irreversibly inhibiting the P2Y12 receptor on platelets, which is essential for platelet activation and aggregation. By blocking this receptor, ticlopidine effectively reduces the risk of clot formation. This mechanism is key to its therapeutic effects in preventing ischemic events.

## **Why Each Wrong Option is Incorrect**
- **Option A:** This option is incorrect because ticlopidine does not belong to the category of drugs that directly affect coagulation factors like warfarin (a vitamin K antagonist).
- **Option B:** This option is incorrect as ticlopidine is not a nonsteroidal anti-inflammatory drug (NSAID). While NSAIDs can have antiplatelet effects by inhibiting COX-1 and thus thromboxane A2 production, ticlopidine's mechanism is distinct and involves the P2Y12 receptor.
- **Option D:** This option is incorrect because ticlopidine is not classified as a glycoprotein IIb/IIIa inhibitor. Drugs like abciximab work by directly inhibiting the glycoprotein IIb/IIIa receptor on platelets, preventing fibrinogen binding and platelet aggregation.

## **Clinical Pearl / High-Yield Fact**
A key clinical pearl about ticlopidine is that, despite its efficacy as an antiplatelet agent, it can cause **severe hematologic side effects**, including neutropenia and thrombotic thrombocytopenic purpura (TTP), which necessitate regular monitoring of blood counts. This is a critical consideration in its use.

## **Correct Answer:** C. Thienopyridine.